Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 1
2007 1
2013 1
2014 1
2016 1
2017 3
2019 2
2020 2
2021 2
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Dinaciclib, a Bimodal Agent Effective against Endometrial Cancer.
Howard D, James D, Murphy K, Garcia-Parra J, Pan-Castillo B, Rex S, Moul A, Jones E, Bilbao-Asensio M, Michue-Seijas S, Lutchman-Singh K, Margarit L, Francis LW, Rees P, Gonzalez D, Conlan RS. Howard D, et al. Among authors: lutchman singh k. Cancers (Basel). 2021 Mar 6;13(5):1135. doi: 10.3390/cancers13051135. Cancers (Basel). 2021. PMID: 33800911 Free PMC article.
Rare presentation of endometrial cancer with uterine inversion.
Hablase R, Das N, Lutchman Singh K. Hablase R, et al. Among authors: lutchman singh k. Int J Gynecol Cancer. 2023 May 1;33(5):848. doi: 10.1136/ijgc-2022-004088. Int J Gynecol Cancer. 2023. PMID: 37127327 No abstract available.
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
Quintela M, James DW, Garcia J, Edwards K, Margarit L, Das N, Lutchman-Singh K, Beynon AL, Rioja I, Prinjha RK, Harker NR, Gonzalez D, Steven Conlan R, Francis LW. Quintela M, et al. Among authors: lutchman singh k. Br J Cancer. 2023 Jul;129(1):163-174. doi: 10.1038/s41416-023-02274-2. Epub 2023 Apr 29. Br J Cancer. 2023. PMID: 37120667 Free PMC article.
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer.
Howard D, James D, Garcia-Parra J, Pan-Castillo B, Worthington J, Williams N, Coombes Z, Rees SC, Lutchman-Singh K, Francis LW, Rees P, Margarit L, Conlan RS, Gonzalez D. Howard D, et al. Among authors: lutchman singh k. Front Oncol. 2022 Nov 25;12:1014280. doi: 10.3389/fonc.2022.1014280. eCollection 2022. Front Oncol. 2022. PMID: 36505806 Free PMC article.
Cu isotope ratios are meaningful in ovarian cancer diagnosis.
Toubhans B, Gourlan AT, Telouk P, Lutchman-Singh K, Francis LW, Conlan RS, Margarit L, Gonzalez D, Charlet L. Toubhans B, et al. Among authors: lutchman singh k. J Trace Elem Med Biol. 2020 Dec;62:126611. doi: 10.1016/j.jtemb.2020.126611. Epub 2020 Jul 3. J Trace Elem Med Biol. 2020. PMID: 32652467 Free article.
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.
Quintela M, James DW, Pociute A, Powell L, Edwards K, Coombes Z, Garcia J, Garton N, Das N, Lutchman-Singh K, Margarit L, Beynon AL, Rioja I, Prinjha RK, Harker NR, Gonzalez D, Conlan RS, Francis LW. Quintela M, et al. Among authors: lutchman singh k. Clin Epigenetics. 2023 Apr 15;15(1):63. doi: 10.1186/s13148-023-01477-x. Clin Epigenetics. 2023. PMID: 37060086 Free PMC article.
20 results